文献速递乳房整形与再造创面修复显微修复重建

质子与光子乳房切除术后放疗在前置假体乳房重建中的结局比较

Comparative Outcomes of Proton versus Photon Postmastectomy Radiation Therapy in Prepectoral Implant-Based Breast Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2025-05-28

光子放疗组75例、质子放疗组41例;质子放疗组总体并发症更少,光子放疗与≥2种并发症风险升高独立相关。

要点

  • 质子放疗组总体并发症少于光子放疗组。
  • 光子放疗与≥2种并发症风险升高相关(多变量OR 4.84)。
  • 肿瘤分期3/4期也与≥2种并发症风险升高相关。

核心结论

  • 与传统光子放疗相比,质子放疗与PP-IBBR患者更少的并发症相关。
  • 作者认为质子放疗是更安全的选择,值得更大规模研究及更广泛临床应用。

研究设计与样本

  • 共分析116例PP-IBBR接受PMRT患者,分为光子放疗组(n=75,64.7%)和质子放疗组(n=41,35.3%)。
  • 评估轻微感染(需口服抗生素)、严重感染(需静脉抗生素)、伤口并发症、皮瓣坏死、血清肿、再手术、包膜挛缩及假体失败(因上述并发症需取出假体,破裂除外,包括假体外露)。

主要发现

  • 光子放疗组总体并发症多于质子放疗组。
  • 严重感染、轻微感染、伤口延迟愈合、部分皮瓣坏死、血清肿形成、再手术、假体失败、各级包膜挛缩及III或IV级包膜挛缩在光子放疗组均多于质子放疗组。
  • 单变量分析中,光子放疗与≥2种并发症风险升高显著相关(OR 3.71,95%CI 1.02–13.53,P=0.047)。
  • 多变量模型校正分期后,光子放疗与≥2种并发症风险升高显著相关(OR 4.84,95%CI 1.27–18.46,P=0.021)。
  • 校正放疗类型后,与1/2期相比,3/4期与≥2种并发症风险升高显著相关(OR 3.40,95%CI 1.21–9.57,P=0.021)。

关键数值与推荐

  • 证据等级:治疗性,III级。

临床怎么用

  • 在PP-IBBR需PMRT的患者中,选择质子放疗可能降低总体并发症及≥2种并发症风险。
  • 光子放疗者需更关注感染、伤口愈合、皮瓣坏死、血清肿、再手术及假体失败等风险。
  • 肿瘤分期3/4期患者并发症风险更高,术前咨询应纳入分期因素。

局限性

  • 单中心回顾性设计,样本量有限(116例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The increasing popularity of prepectoral implant-based breast reconstruction (PP-IBBR) and proton-based radiation (PRT) lacks outcomes data. The authors compared complications in PP-IBBR with photon-based radiation (XRT) versus PRT postmastectomy radiotherapy (PMRT). METHODS: A single-institution retrospective cohort study included patients with breast cancer undergoing mastectomy and PP-IBBR with PMRT (January 2020 to October 2022) with 2-year follow-up after surgery. The authors assessed for minor infections (requiring oral antibiotics), major infections (requiring intravenous antibiotics), wound complications, flap necrosis, seromas, reoperations, capsular contracture, and implant failures (requiring implant removal for any of the aforementioned complications, except for rupture), including implant exposure. RESULTS: A total of 116 patients with PP-IBBR receiving PMRT were analyzed, divided into 2 cohorts: XRT ( n = 75 [64.7%]) and PRT ( n = 41 [35.3%]). Overall, more complications occurred with XRT compared with PRT. Major infection, minor infection, delayed wound healing, partial flap necrosis, seroma development, reoperations, implant failure, and capsular contracture of all grades as well as grade III or IV capsular contracture were seen more with XRT compared with PRT. Compared with PRT, XRT was significantly associated with higher risk of 2 or more complications in univariable analysis (OR, 3.71 [95% CI, 1.02 to 13.53]; P = 0.047) and in the multivariable model adjusting for stage (OR, 4.84 [95% CI, 1.27 to 18.46]; P = 0.021). Compared with stages 1 and 2, stages 3 and 4 were significantly associated with higher risk of 2 or more complications (OR, 3.40 [95% CI, 1.21 to 9.57]; P = 0.021), adjusting for radiation type. CONCLUSIONS: Compared with traditional XRT, PRT was associated with fewer complications in patients with PP-IBBR. PRT is a safer option, warranting larger studies and broader utilization in clinical practice. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Desai A, Padilla C, Choi S, et al. Comparative Outcomes of Proton versus Photon Postmastectomy Radiation Therapy in Prepectoral Implant-Based Breast Reconstruction. Plast Reconstr Surg. 2025. PMID: 40489749. doi:10.1097/PRS.0000000000012232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。